How much debt does Gracell Biotechnologies have?

According to Gracell Biotechnologies's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Gracell Biotechnologies's total debt stands at $182.98M. This is broken down into:

• Long-term debt: $52.99M
• Short-term debt: $129.99M

The company's net debt, which accounts for cash and cash equivalents, is $-1.27B. In terms of overall financial obligations, Gracell Biotechnologies's total liabilities amount to $280.51M.

Debt Ratios and Metrics

To better understand Gracell Biotechnologies's debt position, we can look at several key ratios:

• Debt to Equity Ratio: 0.13 - this indicates the proportion of equity and debt the company uses to finance its assets.
• Debt Ratio: 11.05% - this shows the proportion of a company's assets that are financed through debt.
• Interest Coverage Ratio: -92.72 - this measures how easily a company can pay interest on its outstanding debt.
• Long-term Debt to Capitalization: 3.71% - this shows the proportion of long-term debt in the company's capital structure.
• Total Debt to Capitalization: 11.74% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Gracell Biotechnologies's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.